0001179110-15-006161.txt : 20150409 0001179110-15-006161.hdr.sgml : 20150409 20150409075714 ACCESSION NUMBER: 0001179110-15-006161 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150409 FILED AS OF DATE: 20150409 DATE AS OF CHANGE: 20150409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danilkovitch Alla CENTRAL INDEX KEY: 0001636236 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 15760359 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE STREET 2: OSIRIS THERAPEUTICS, INC. CITY: COLUMBIA STATE: MD ZIP: 21046 3 1 edgar.xml FORM 3 - X0206 3 2015-04-09 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001636236 Danilkovitch Alla C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046-1707 0 1 0 0 Chief Scientific Officer Common Stock 5375 D Non-Qualified Stock Option (right to buy) 0.40 2006-12-01 2015-12-01 Common Stock 5000 D Incentive Stock Option (right to buy) 12.50 2008-07-26 2017-07-26 Common Stock 3000 D Incentive Stock Option (right to buy) 17.10 2009-10-02 2018-10-02 Common Stock 3000 D Incentive Stock Option 7.74 2011-03-12 2020-03-12 Common Stock 8000 D Incentive Stock Option (right to buy) 6.46 2011-05-27 2020-05-27 Common Stock 5000 D Incentive Stock Option (right to buy) 7.13 2012-02-14 2021-02-14 Common Stock 9000 D Incentive Stock Option (right to buy) 5.08 2013-03-23 2022-03-23 Common Stock 10000 D Incentive Stock Option (right to buy) 7.73 2013-02-12 2023-02-12 Common Stock 10000 D Non-Qualified Stock Option (right to buy) 14 2015-05-06 2024-05-06 Common Stock 1436 D Incentive Stock Option (right to buy) 14 2015-05-06 2024-05-06 Common Stock 18564 D Non-Qualified Stock Option (right to buy) 18.40 2016-03-06 2025-03-06 Common Stock 17356 D Incentive Stock Option (right to buy) 18.4 2016-03-06 2025-03-06 Common Stock 7644 D The option to purchase shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to the underlying shares as of the date of this Form 3. The option to purchase 10,000 shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to 7,500 of the underlying shares and the remaining 2,500 options shall become exercisable on March 23, 2016, assuming the Reporting Person continues to be employed by the Registrant on the vesting date. The option to purchase 10,000 shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to 5,000 of the underlying shares and the remaining 5,000 options shall become vested, 2,500 on February 12, 2016 and 2,500 on February 12, 2017, assuming the Reporting Person continues to be employed by the Registrant on the vesting dates. The option to purchase 20,000 shares of Osiris Therapeutics, Inc. common stock shall become exercisable with respect to the underlying shares as to 25% on each May 6, 2015, 2016, 2017 and 2018, assuming the Reporting Person continues to be employed by the Registrant on the vesting date. The option to purchase 25,000 shares of Osiris Therapeutics, Inc. common stock shall become exercisable with respect to the underlying shares as to 25% on each March 6, 2016, 2017, 2018 and 2019, assuming the Reporting Perosn continues to be employed by the Registrant on the vesting date Alla Danilkovitch 2015-04-09